Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biocompatible Materials | 12 | 2025 | 123 | 4.610 |
Why?
|
| Tissue Engineering | 10 | 2025 | 168 | 4.020 |
Why?
|
| Collagen | 6 | 2025 | 289 | 3.070 |
Why?
|
| Aptamers, Nucleotide | 3 | 2025 | 39 | 2.010 |
Why?
|
| Tissue Scaffolds | 8 | 2022 | 92 | 1.900 |
Why?
|
| Neovascularization, Physiologic | 4 | 2025 | 205 | 1.690 |
Why?
|
| Hydrogels | 2 | 2025 | 101 | 1.510 |
Why?
|
| Blood Vessel Prosthesis | 4 | 2022 | 474 | 1.490 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 4 | 2025 | 66 | 1.420 |
Why?
|
| Bone Regeneration | 2 | 2020 | 35 | 1.240 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 7 | 2025 | 105 | 1.050 |
Why?
|
| DNA | 2 | 2025 | 1440 | 1.030 |
Why?
|
| Regenerative Medicine | 2 | 2025 | 39 | 0.990 |
Why?
|
| Nucleic Acids | 1 | 2025 | 26 | 0.930 |
Why?
|
| DNA, Single-Stranded | 2 | 2025 | 73 | 0.830 |
Why?
|
| Stress, Mechanical | 2 | 2021 | 178 | 0.800 |
Why?
|
| Orthopedics | 2 | 2014 | 78 | 0.760 |
Why?
|
| Endothelial Cells | 2 | 2019 | 530 | 0.730 |
Why?
|
| Free Radical Scavengers | 2 | 2019 | 56 | 0.710 |
Why?
|
| Polymers | 3 | 2018 | 111 | 0.690 |
Why?
|
| Aptamers, Peptide | 1 | 2020 | 4 | 0.670 |
Why?
|
| Oligopeptides | 1 | 2020 | 107 | 0.640 |
Why?
|
| Minerals | 1 | 2020 | 59 | 0.640 |
Why?
|
| Magnoliopsida | 1 | 2019 | 5 | 0.630 |
Why?
|
| Materials Testing | 7 | 2019 | 80 | 0.630 |
Why?
|
| Textiles | 1 | 2019 | 12 | 0.620 |
Why?
|
| Citrates | 2 | 2018 | 25 | 0.600 |
Why?
|
| Alloys | 5 | 2018 | 17 | 0.590 |
Why?
|
| Cerium | 2 | 2019 | 8 | 0.580 |
Why?
|
| Elastin | 1 | 2018 | 32 | 0.570 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 344 | 0.570 |
Why?
|
| Collagen Type I | 1 | 2018 | 114 | 0.560 |
Why?
|
| Ceramics | 2 | 2014 | 13 | 0.510 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2018 | 232 | 0.500 |
Why?
|
| Cell Line | 5 | 2021 | 2591 | 0.480 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2016 | 11 | 0.480 |
Why?
|
| Weightlessness Simulation | 1 | 2016 | 23 | 0.470 |
Why?
|
| Blood Vessels | 1 | 2016 | 99 | 0.460 |
Why?
|
| Cell Survival | 4 | 2020 | 849 | 0.430 |
Why?
|
| Barium Compounds | 1 | 2013 | 6 | 0.410 |
Why?
|
| Osteoblasts | 4 | 2020 | 158 | 0.410 |
Why?
|
| Titanium | 1 | 2013 | 26 | 0.400 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 2019 | 124 | 0.380 |
Why?
|
| Cells, Cultured | 5 | 2021 | 2947 | 0.370 |
Why?
|
| Acute Chest Syndrome | 1 | 2011 | 10 | 0.350 |
Why?
|
| Cell Differentiation | 2 | 2017 | 1950 | 0.350 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2019 | 186 | 0.350 |
Why?
|
| Humans | 25 | 2025 | 132041 | 0.320 |
Why?
|
| Endothelium | 1 | 2010 | 63 | 0.310 |
Why?
|
| Magnesium | 4 | 2018 | 121 | 0.290 |
Why?
|
| Anemia, Sickle Cell | 1 | 2011 | 325 | 0.260 |
Why?
|
| Animals | 8 | 2025 | 34262 | 0.230 |
Why?
|
| Aorta | 2 | 2019 | 530 | 0.230 |
Why?
|
| Anesthetics, Dissociative | 1 | 2005 | 18 | 0.230 |
Why?
|
| Stem Cells | 1 | 2010 | 714 | 0.220 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 1214 | 0.210 |
Why?
|
| Orthopedic Surgeons | 1 | 2024 | 14 | 0.210 |
Why?
|
| von Willebrand Factor | 2 | 2019 | 192 | 0.210 |
Why?
|
| Humeral Fractures | 1 | 2024 | 26 | 0.210 |
Why?
|
| Radiologists | 1 | 2024 | 54 | 0.200 |
Why?
|
| Strontium | 3 | 2018 | 5 | 0.200 |
Why?
|
| Observer Variation | 1 | 2024 | 319 | 0.200 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2477 | 0.190 |
Why?
|
| Absorbable Implants | 4 | 2018 | 25 | 0.180 |
Why?
|
| Elastomers | 1 | 2022 | 4 | 0.180 |
Why?
|
| Phenotype | 3 | 2021 | 4540 | 0.180 |
Why?
|
| Cell Death | 2 | 2020 | 237 | 0.180 |
Why?
|
| Ketamine | 1 | 2005 | 229 | 0.170 |
Why?
|
| Financial Management | 1 | 2021 | 14 | 0.170 |
Why?
|
| Durapatite | 1 | 2020 | 11 | 0.160 |
Why?
|
| Chemical Phenomena | 1 | 2020 | 48 | 0.160 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2020 | 88 | 0.160 |
Why?
|
| Macromolecular Substances | 1 | 2020 | 131 | 0.160 |
Why?
|
| Spectrum Analysis | 1 | 2020 | 62 | 0.160 |
Why?
|
| Nanocomposites | 1 | 2019 | 7 | 0.160 |
Why?
|
| Tensile Strength | 1 | 2019 | 46 | 0.160 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 95 | 0.150 |
Why?
|
| Polyesters | 1 | 2019 | 38 | 0.150 |
Why?
|
| Calcium Phosphates | 1 | 2019 | 20 | 0.150 |
Why?
|
| Mice | 4 | 2025 | 18394 | 0.150 |
Why?
|
| Nucleotides | 1 | 2019 | 90 | 0.150 |
Why?
|
| Precision Medicine | 1 | 2023 | 381 | 0.150 |
Why?
|
| Citric Acid | 1 | 2019 | 45 | 0.150 |
Why?
|
| Research Personnel | 1 | 2021 | 139 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 1147 | 0.150 |
Why?
|
| Biomimetic Materials | 1 | 2018 | 15 | 0.150 |
Why?
|
| Male | 8 | 2024 | 65425 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 157 | 0.140 |
Why?
|
| Arteries | 1 | 2018 | 210 | 0.130 |
Why?
|
| Female | 8 | 2024 | 71380 | 0.130 |
Why?
|
| Cell Movement | 1 | 2020 | 882 | 0.130 |
Why?
|
| Asthma | 1 | 2005 | 928 | 0.120 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 1996 | 20 | 0.120 |
Why?
|
| Inflammation | 2 | 2014 | 1503 | 0.120 |
Why?
|
| Osteogenesis | 1 | 2017 | 167 | 0.120 |
Why?
|
| Bioreactors | 1 | 2016 | 44 | 0.120 |
Why?
|
| Sus scrofa | 1 | 2016 | 115 | 0.120 |
Why?
|
| Tibia | 1 | 2015 | 81 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 152 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2021 | 559 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2015 | 187 | 0.110 |
Why?
|
| Scandium | 1 | 2014 | 1 | 0.110 |
Why?
|
| Yttrium | 1 | 2014 | 6 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 359 | 0.110 |
Why?
|
| Pre-Eclampsia | 1 | 1996 | 223 | 0.110 |
Why?
|
| Gadolinium | 1 | 2014 | 112 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 360 | 0.100 |
Why?
|
| Polytetrafluoroethylene | 1 | 2012 | 62 | 0.090 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 99 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2015 | 1571 | 0.090 |
Why?
|
| Triage | 1 | 2013 | 153 | 0.090 |
Why?
|
| Spirometry | 1 | 2011 | 91 | 0.090 |
Why?
|
| Heparin | 1 | 2012 | 206 | 0.090 |
Why?
|
| Hospitalization | 2 | 2013 | 1944 | 0.080 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2010 | 24 | 0.080 |
Why?
|
| Cadherins | 1 | 2010 | 178 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2010 | 418 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2010 | 771 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2024 | 17748 | 0.070 |
Why?
|
| Adolescent | 4 | 2024 | 21018 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1614 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2098 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3703 | 0.060 |
Why?
|
| Infusions, Parenteral | 1 | 2005 | 78 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 241 | 0.060 |
Why?
|
| Texas | 1 | 2013 | 3646 | 0.050 |
Why?
|
| Bronchodilator Agents | 1 | 2005 | 154 | 0.050 |
Why?
|
| Pediatric Emergency Medicine | 1 | 2024 | 46 | 0.050 |
Why?
|
| Incidence | 1 | 2011 | 3358 | 0.050 |
Why?
|
| Emergency Medicine | 1 | 2005 | 176 | 0.050 |
Why?
|
| Thermodynamics | 2 | 2014 | 148 | 0.050 |
Why?
|
| Photoelectron Spectroscopy | 2 | 2012 | 9 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2015 | 4696 | 0.050 |
Why?
|
| Child | 3 | 2024 | 26361 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2014 | 432 | 0.050 |
Why?
|
| Radiography | 1 | 2024 | 763 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2011 | 5124 | 0.040 |
Why?
|
| Prognosis | 1 | 2011 | 4962 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2005 | 1637 | 0.040 |
Why?
|
| Calcium | 2 | 2017 | 1039 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 135 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2013 | 8613 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2024 | 15089 | 0.040 |
Why?
|
| Risk Factors | 1 | 2013 | 11020 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 3003 | 0.030 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 1996 | 4 | 0.030 |
Why?
|
| Adult | 3 | 2012 | 31747 | 0.030 |
Why?
|
| Phosphatidylserines | 1 | 1996 | 46 | 0.030 |
Why?
|
| Bone Nails | 1 | 2015 | 27 | 0.030 |
Why?
|
| Hydrogen | 1 | 2015 | 42 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 5287 | 0.030 |
Why?
|
| Pediatrics | 1 | 2005 | 1243 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 101 | 0.030 |
Why?
|
| Corrosion | 1 | 2014 | 2 | 0.030 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2012 | 31 | 0.020 |
Why?
|
| Platelet Adhesiveness | 1 | 2012 | 36 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2012 | 100 | 0.020 |
Why?
|
| Cell Shape | 1 | 2012 | 70 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 310 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2012 | 319 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2012 | 469 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 3458 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2005 | 13025 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 13343 | 0.020 |
Why?
|
| Thrombosis | 1 | 2012 | 497 | 0.020 |
Why?
|
| United States | 1 | 2021 | 11846 | 0.010 |
Why?
|
| Pregnancy | 1 | 1996 | 7588 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6283 | 0.010 |
Why?
|